Sonia Quaratino

Chief Medical Officer

Kymab

Dr Sonia Quaratino joined Kymab in 2017, responsible for the clinical strategy and execution of Kymab’s
first-in-class and innovative programs in immunology and immuno-oncology through pre-clinical and early stage clinical trials. She has over 25 years of experience in industry and academic research with a broad experience as a clinical leader developing both cancer vaccines, small molecules and antibodies for solid and haematological malignancies. Before joining Kymab, she served as Global Clinical Program Leader at Novartis in Basel and prior to that, she was Senior Medical Director in Oncology Early Clinical Development and Advisor in Immunology at Merck Serono in Darmstadt. She received her MD from the University of Palermo School of Medicine, completed her doctorate between the University of Palermo and Imperial College London and served as Professor in Immunology at the University of Southampton.